Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Choosing between Willow and Medivive for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Willow offers both semaglutide and tirzepatide at $299/month with a rating of 7.4/10. Medivive also provides both semaglutide and tirzepatide at $162/month with a 7.4/10 rating.
The price difference of $137/month is significant - Medivive is the more budget-friendly option, while Willow positions itself as a premium service.
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
| Feature | Willow | Medivive |
|---|---|---|
| Monthly Price | $299 | $162 |
| Rating | 7.4/10 | 7.4/10 |
| Medications | semaglutide, tirzepatide | semaglutide, tirzepatide |
| Insurance Accepted | No | No |
| Support Hours | 24/7 online support claimed | Not published |
| Live Chat | No | No |
| Free Shipping | Yes | Yes |
| Shipping Speed | Not published; same-day prescription review claimed | Delivered to your door; refills arrive on schedule |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | Unlimited doctor messaging and free follow-ups claimed | Provider adjusts treatment over time as labs change; no fixed schedule published |
| Money-back Guarantee | Full refund only if you cancel before the prescription reaches the pharmacy; no returns on medication once dispensed | Nothing to pay until a provider reviews your case |
| Cancellation Policy | Cancel anytime, but the request must arrive two full calendar days before your next shipping date | Billed monthly; cancellation terms not published |

